Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug DiscoveryGenome-based Drug DiscoveryArtificial IntelligenceAI Drug Discovery

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1656212

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1656212

Artificial Intelligence (AI) in Genomics

PUBLISHED:
PAGES: 210 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Artificial Intelligence (AI) in Genomics Market to Reach US$8.7 Billion by 2030

The global market for Artificial Intelligence (AI) in Genomics estimated at US$1.1 Billion in the year 2024, is expected to reach US$8.7 Billion by 2030, growing at a CAGR of 40.6% over the analysis period 2024-2030. Genomics AI Software, one of the segments analyzed in the report, is expected to record a 43.7% CAGR and reach US$4.6 Billion by the end of the analysis period. Growth in the Genomics AI Services segment is estimated at 39.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$319.4 Million While China is Forecast to Grow at 37.4% CAGR

The Artificial Intelligence (AI) in Genomics market in the U.S. is estimated at US$319.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 37.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 36.5% and 33.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 25.8% CAGR.

Global Artificial Intelligence (AI) in Genomics Market - Key Trends and Drivers Summarized

Artificial Intelligence (AI) is revolutionizing genomics, significantly enhancing the accuracy and speed of genome sequencing and genetic analysis. By integrating AI with genomics, researchers and healthcare providers can more quickly decode genetic material, facilitating advancements in personalized medicine where treatment plans are tailored to individual genetic profiles. AI's capacity to handle vast datasets gleaned from electronic medical records has expanded its applications across healthcare, agriculture, and environmental science, contributing to more targeted disease management and therapy options. For instance, AI algorithms can analyze patient health trajectories and predict outcomes with greater precision than traditional methods, profoundly impacting the development of personalized medical approaches and treatments.

In gene therapy, AI plays a pivotal role by providing tools to design effective interventions by analyzing complex genetic data. This capability is vital in enhancing the understanding and treatment of diseases at the genetic level. RNA sequencing technologies, especially RNA-Seq, benefit from AI by offering more accurate quantifications of gene expressions and their variations, thus providing deeper insights into biological processes and potential disease mechanisms. These advancements are not only accelerating the pace of research but also improving the quality and effectiveness of medical treatments and gene therapies, underscoring the critical role of AI in pushing the boundaries of modern medicine and scientific understanding.

However, the integration of AI into genomics raises significant challenges and ethical considerations, particularly concerning the protection and privacy of genetic data and the moral implications of genetic editing. Ensuring the security of sensitive genetic information and adhering to strict regulatory standards are paramount as AI and genomics become more intertwined. Moreover, ethical debates surrounding the potential for creating designer genes highlight the need for careful consideration of how these technologies are applied. The growth of AI in genomics is also driven by factors such as advancements in AI and machine learning technologies, the exponential increase in genomic data, and the growing emphasis on precision medicine. Additionally, reduced sequencing costs, the demand for drug development, strategic collaborations, and increased public and private investment all contribute to the expansion of AI applications in genomics, promising to further advance the field and expand its impact on various aspects of healthcare and medicine.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence (AI) in Genomics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Software, Services, Hardware); Technology (Machine Learning, Other Technologies); Functionality (Genome Sequencing, Gene Editing, Other Functionalities); Application (Drug Discovery & Development, Precision Medicine, Diagnostics, Other Applications); End-User (Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 23 Featured) -

  • Data4Cure
  • Deep Genomics
  • Fabric Genomics (formerly Omicia)
  • Freenome, Inc.
  • Genoox
  • IBM Corporation
  • Illumina, Inc.
  • Microsoft Corporation
  • NVIDIA Corporation
  • Sophia Genetics
Show more
Product Code: MCP23213

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Artificial Intelligence (AI) in Genomics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • AI-Driven Gene Editing is Finally Here!
    • Data Analysis Acceleration by AI Spurs Growth in Genomic Research
    • AI for Predictive Genomics Expand Market Opportunities
    • Integration of AI with CRISPR Technology Strengthens Business Case for Genetic Engineering
    • Enhanced Newborn Screening Capabilities Through AI-Driven Genomic Interpretations
    • AI-Enhanced Diagnostic Tools for Genetic Disorders Drive Clinical Adoption
    • AI's Role in Oncology Genomics Throws the Spotlight On Cancer Treatment
    • AI-Powered Therapeutic Discovery Drives Innovations in Drug Development
    • AI's Impact on Agricultural Genomics Spurs Advances in Crop Science
    • AI in Genomic Data Privacy Issues Shape Regulatory and Ethical Debates
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence (AI) in Genomics Market Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Artificial Intelligence (AI) in Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 4: World 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2022, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 7: World 8-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 10: World 8-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 13: World 8-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Precision Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Precision Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 16: World 8-Year Perspective for Precision Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 19: World 8-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 22: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 25: World 8-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 28: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals & Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals & Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 31: World 8-Year Perspective for Hospitals & Healthcare Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 34: World 8-Year Perspective for Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 37: World 8-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Machine Learning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Machine Learning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 40: World 8-Year Perspective for Machine Learning by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 43: World 8-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 46: World 8-Year Perspective for Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Gene Editing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Gene Editing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 49: World 8-Year Perspective for Gene Editing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Other Functionalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Other Functionalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 52: World 8-Year Perspective for Other Functionalities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 53: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 55: USA 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 58: USA 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 61: USA 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 62: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 64: USA 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 65: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 67: USA 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • CANADA
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 70: Canada 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 73: Canada 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 76: Canada 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Canada Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 79: Canada 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 80: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Canada Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 82: Canada 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • JAPAN
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 85: Japan 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 88: Japan 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 89: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Japan Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 91: Japan 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 92: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Japan Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 94: Japan 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 95: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Japan Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 97: Japan 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • CHINA
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 98: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: China Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 100: China 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 101: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: China Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 103: China 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 104: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: China Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 106: China 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 107: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: China Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 109: China 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 110: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: China Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 112: China 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • EUROPE
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 113: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 114: Europe Historic Review for Artificial Intelligence (AI) in Genomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 115: Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2022, 2025 & 2030
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 118: Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 119: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Europe Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 121: Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 122: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Europe Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 124: Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 125: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Europe Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 127: Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 128: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Europe Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 130: Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • FRANCE
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 131: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: France Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 133: France 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 134: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: France Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 136: France 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 137: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: France Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 139: France 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 140: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: France Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 142: France 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 143: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: France Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 145: France 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • GERMANY
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 146: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Germany Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 148: Germany 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 149: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Germany Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 151: Germany 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 152: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Germany Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 154: Germany 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 155: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Germany Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 157: Germany 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 158: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Germany Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 160: Germany 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • ITALY
    • TABLE 161: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Italy Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 163: Italy 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 164: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Italy Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 166: Italy 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 167: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Italy Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 169: Italy 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 170: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Italy Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 172: Italy 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 173: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Italy Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 175: Italy 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 176: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: UK Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 178: UK 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 179: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: UK Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 181: UK 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 182: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: UK Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 184: UK 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 185: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: UK Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 187: UK 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 188: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UK Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 190: UK 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • REST OF EUROPE
    • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Europe Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 193: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Europe Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 196: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Europe Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 199: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Europe Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 202: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Europe Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 205: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 208: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 211: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 214: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 217: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 220: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • REST OF WORLD
    • TABLE 221: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Rest of World Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 223: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 224: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of World Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 226: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 227: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of World Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 229: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 230: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of World Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 232: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 233: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of World Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 235: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!